State Of Wyoming Syros Pharmaceuticals, Inc. Transaction History

State Of Wyoming

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.02 - $3.8 $1,042 - $3,883	-1,022 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$3.26 - $4.66 $6 - $9	-2 Reduced 0.2%	1,022 $3,000
Q3 2021 Feb 11, 2022	BUY	$4.08 - $5.66 $3,296 - $4,573	808 Added 374.07%	1,024 $5,000
Q2 2021 Feb 11, 2022	BUY	$5.01 - $7.48 $1,082 - $1,615	216 New	216 $1,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.